Studying Health Outcomes after Treatment in Patients with Retinoblastoma, RIVERBOAT Study

This trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members through vision assessments, samples of tissue and saliva, and questionnaires may help doctors learn more about what causes retinoblastoma, identify long-term health outcomes for patients with retinoblastoma, and find out which therapies may be the best for treating retinoblastoma.

Disease Sites:

Pediatrics, Retinoblastoma (Pediatrics)

Staging:

N/A

Age Group:

Children

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Friedman, Debra

Scope:

Local

Participating Institutions:

Children's Hospital of Philadelphia, Cincinnati Children's Hospital, M.D. Anderson Cancer Center, Houston, Medical College of Wisconsin, Northwestern University, Texas Children's Hospital, The Hospital for Sick Children - Toronto, University of Illinois-Chicago, University of Minnesota, Vanderbilt University, Washington University

Open Date:

01-24-2019

Trial Type:

Health Services Research

Protocol ID:

VICCPED1878

National Clinical Trial ID:

NCT03932786